$AD

Research Analysts’ Price Target Changes for May 26th (ACQ, AD, ADI, AMTM, AUNA, AVEX, BAH, BJ, CAE, CIEN)

On May 26, analysts adjusted price targets across multiple stocks. Royal Bank raised AutoCanada to C$23. JPMorgan cut Array Digital Infrastructure to $54 and Amentum to $31, but raised Analog Devices to $450. Other changes included BofA lifting Ciena to $660 and Cisco to $135, and Stifel trimming CAE to C$47.

Original reporting
Published May 26, 2026, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 7:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Research Analysts’ Price Target Changes for May 26th (ACQ, AD, ADI, AMTM, AUNA, AVEX, BAH, BJ, CAE, CIEN) — source image
Decision brief

The 30-second read

$ADBearishMed
01

Why it matters

Because it lists only target/rating revisions (no underlying operational catalyst), the most likely trading impact is sentiment/positioning and relative-value rotation rather than fundamental repricing.

02

Market read

Use the direction of target changes and the accompanying rating (overweight/underweight/buy/underperform) to gauge near-term sentiment and relative-value trades.

03

What to watch

Relative performance may be driven more by the stated rating (overweight/underweight) than the numeric target; also, currency effects for Canadian names can distort perceived magnitude.

Relevance 7/10Timing: Immediate (analyst revision day); follow-through depends on whether traders treat targets as catalysts.

Background

The article is a compilation of analyst price-target changes for multiple companies on May 26, 2026, with accompanying rating stances.

Company-level read

Ticker impact

$ADBearishMedium confidence
Context

JPMorgan trimmed Array Digital Infrastructure’s price target from $60 to $54, signaling a reduced outlook despite an overweight rating.

Expected impact

Mild-to-moderate downside bias versus peers until new catalysts emerge.

Evidence & confidence

The article is solely about a target change; without fundamentals, impact is likely sentiment-driven rather than fundamental repricing.

$ADIBullishMedium confidence
Context

JPMorgan raised Analog Devices’ price target from $400 to $450 while keeping an overweight stance.

Expected impact

Moderate upside bias, especially if the market is already underweight the name.

Evidence & confidence

Price-target hikes often support flows, but magnitude and timing depend on broader earnings/guide context not provided here.

$AMTMBearishMedium confidence
Context

JPMorgan reduced Amentum’s price target from $34 to $31, moving expectations lower with a neutral rating.

Expected impact

Slight downside or limited upside until the next earnings cycle.

Evidence & confidence

Neutral rating reduces urgency, but the cut still signals expectation trimming.

$AUNABearishMedium confidence
Context

JPMorgan cut Auna’s price target from $6 to $5, maintaining a neutral rating.

Expected impact

Low-to-moderate downside bias, mainly affecting traders sensitive to analyst revisions.

Evidence & confidence

Neutral rating suggests conviction is not high; impact likely incremental.

$AVEXBullishMedium confidence
Context

JPMorgan increased AEVEX’s price target from $33 to $35 and kept an overweight rating.

Expected impact

Mild upside bias; could attract incremental long interest.

Evidence & confidence

The article provides no rationale; confidence is limited to the directionality of the revision.

$BAHBearishMedium confidence
Context

JPMorgan lowered Booz Allen Hamilton’s price target from $97 to $85 while holding an underweight rating.

Expected impact

Moderate downside risk, particularly if the market treats analyst cuts as near-term guidance.

Evidence & confidence

Large delta (97→85) increases the chance of sentiment-driven selling, though no catalyst is cited.

$BJBullishMedium confidence
Context

JPMorgan boosted BJ’s Wholesale Club price target from $90 to $98, with a neutral rating.

Expected impact

Slight upside bias; less likely to trigger aggressive trend changes.

Evidence & confidence

Neutral rating implies balanced view; effect may be limited to revision-sensitive flows.

$CAENeutralMedium confidence
Context

Stifel reduced CAE’s price target from C$50 to C$47 while maintaining a buy rating.

Expected impact

Range-bound to mildly positive, depending on how investors weigh the cut.

Evidence & confidence

A buy rating suggests conviction remains, but the lower target indicates some caution.

Market effects

Broad, cross-sector analyst target revisions; useful for relative-value/positioning rather than a single sector catalyst.

Includes US and Canadian listings; may create localized flow effects in telecom, semis, and defense/IT services.

Limited global linkage; primarily analyst sentiment updates with company-specific implications.

Counterpoint

Price-target changes can lag fundamentals; without earnings/guide details, market may ignore targets and trade only on upcoming results.

Key entities

  • JPMorgan Chase & Co.

    Made multiple target cuts and hikes across several covered equities in the list.

  • Bank of America Corporation

    Raised targets for several tech/telecom/semi names while maintaining buy/underperform/other ratings.

  • Royal Bank of Canada

    Boosted targets for select Canadian-listed names in the list.

  • Stifel Nicolaus

    Reduced CAE’s price target while keeping a buy rating.

Related articles

$HLIOMedAI 8/10

Read Analyst Questions From Helios’s Q2 Earnings Call

Helios (HLIO) reported Q2 results above analyst estimates, citing growth in Hydraulics and Electronics and execution of its CORE Strategy. Order intake rose double digits year over year for the fourth straight quarter, and margin expansion reflected efficiency and favorable mix. Revenue was $231.9M vs $230.3M, adjusted EPS $0.88 vs $0.80, and guidance was raised (revenue midpoint $890M; EPS $3.15).

$HIMSMed

5 Revealing Analyst Questions From Hims & Hers Health’s Q2 Earnings Call

Hims & Hers Health reported Q2 revenue of $753.2M versus $699M estimates and adjusted EBITDA of $60.32M versus $47.26M, but adjusted EPS was -$0.09 versus $0.11. The company lifted full-year revenue guidance to $3.2B and EBITDA guidance to $300M midpoint. Shares fell over 5% amid higher operating expenses and litigation costs, while management cited AI-driven customer acquisition and Eucalyptus integration.

$CSCOMedAI 8/10

Why Cisco (CSCO) Stock Is Down Today

Cisco (CSCO) shares fell about 9% after the company reported fourth-quarter fiscal 2026 results that beat Wall Street on revenue and profit. Cisco said revenue rose to $17.3B, up 18% year over year, and non-GAAP EPS was $1.22. It guided fiscal 2027 revenue to $72.2B-$73.4B. Shares closed at $113.25.

$CSCOMedAI 8/10

Cisco Beat On Every Line, Then Fell On What AI Costs To Ship

Cisco reported record fiscal Q4 revenue of $17.3B, up 18%, and beat earnings, then guided fiscal 2027 above Wall Street after its results. Despite the beat, CSCO shares fell 8.4% on Aug. 13. Cisco cited a heavier hardware mix and memory costs for a 270 bps YoY drop in non-GAAP product gross margin, expecting a slight gross margin headwind in fiscal 2027.

$VOYAMed

VOYA Stock Hits Record High, Tops $100 For The First Time Ever – Report Says Voya Financial Has Been ‘Fielding’ Takeover Interest

Voya Financial (VOYA) rose more than 5% to a record intraday high of $103.85, first above $100, after a Semafor report said it has been “fielding” takeover interest, including from Principal Financial (PFG). The article notes TOMS Capital urged a strategic review and sale last month; sources say neither management nor the board is seeking a deal.